Lipid nanoparticles deliver one-two punch to shrink resistant oral tumors in preclinical models
Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and the number of new cases is predicted to rise by 30% in the next decade. Despite decades of cancer research, treating OSCC remains a challenge. The five-year survival rate is approximately 50%
Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and the number of new cases is predicted to rise by 30% in the next decade. Despite decades of cancer research, treating OSCC remains a challenge. The five-year survival rate is approximately 50% This story matters for Science & Discovery readers tracking student. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. StudentNewsletter curates and briefs the science & discovery stories that matter. Our editorial policy →